These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16115486)

  • 41. Apolipoprotein AIMilano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme.
    Franceschini G; Baio M; Calabresi L; Sirtori CR; Cheung MC
    Biochim Biophys Acta; 1990 Mar; 1043(1):1-6. PubMed ID: 2106917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
    Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
    J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum lipoproteins and lecithin: cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol.
    Weisweiler P; Heinemann V; Schwandt P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):204-6. PubMed ID: 6715090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiency.
    Wang XL; Osuga J; Tazoe F; Okada K; Nagashima S; Takahashi M; Ohshiro T; Bayasgalan T; Yagyu H; Okada K; Ishibashi S
    J Atheroscler Thromb; 2011; 18(8):713-9. PubMed ID: 21597230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.
    Chen Z; Chu D; Castro-Perez JM; Ni W; Zhang A; Krsmanovic ML; Xie D; Shah V; Stout SJ; McLaren DG; Stefanni AC; Lee SH; Roddy TP; Plump AS; Hubbard BK; Vogt TF; Zhou HH
    J Cardiovasc Transl Res; 2011 Dec; 4(6):801-10. PubMed ID: 21822774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
    Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
    Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia.
    Pisciotta L; Fasano T; Calabresi L; Bellocchio A; Fresa R; Borrini C; Calandra S; Bertolini S
    Atherosclerosis; 2008 May; 198(1):145-51. PubMed ID: 17950741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of serum cholesterol esterification rates on the development of diabetes mellitus in a general population.
    Tanaka SI; Fujioka Y; Tsujino T; Ishida T; Hirata KI
    Lipids Health Dis; 2018 Jul; 17(1):180. PubMed ID: 30055622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population.
    Knoblauch H; Bauerfeind A; Krähenbühl C; Daury A; Rohde K; Bejanin S; Essioux L; Schuster H; Luft FC; Reich JG
    Hum Mol Genet; 2002 Jun; 11(12):1477-85. PubMed ID: 12023990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular basis of fish-eye disease in a patient from Spain. Characterization of a novel mutation in the LCAT gene and lipid analysis of the cornea.
    Blanco-Vaca F; Qu SJ; Fiol C; Fan HZ; Pao Q; Marzal-Casacuberta A; Albers JJ; Hurtado I; Gracia V; Pintó X; Martí T; Pownall HJ
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1382-91. PubMed ID: 9261271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.
    Hobbs HH; Leitersdorf E; Leffert CC; Cryer DR; Brown MS; Goldstein JL
    J Clin Invest; 1989 Aug; 84(2):656-64. PubMed ID: 2760205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.
    Yang XP; Inazu A; Honjo A; Koizumi I; Kajinami K; Koizumi J; Marcovina SM; Albers JJ; Mabuchi H
    J Lipid Res; 1997 Mar; 38(3):585-91. PubMed ID: 9101439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.
    Tietjen I; Hovingh GK; Singaraja R; Radomski C; McEwen J; Chan E; Mattice M; Legendre A; Kastelein JJ; Hayden MR
    Biochim Biophys Acta; 2012 Mar; 1821(3):416-24. PubMed ID: 21875686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.